A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population

Br J Dermatol. 1982 Nov;107(5):583-90. doi: 10.1111/j.1365-2133.1982.tb00410.x.

Abstract

Forty-eight acne patients were treated orally with 13-cis-retinoic acid in a double-blind dose response study. There was a marked clinical improvement with a concomitant reduction in sebum excretion rate (SER) and production rate of free fatty acids (FFA). Microbial numbers decreased significantly; the decrease in propionibacteria was greater than that of aerobic bacteria. The decline in micro-organisms occurred after the reduction in sebum and FFA production. This suggests that the effect of the drug upon micro-organisms is secondary to the change in sebum excretion but it is nevertheless an important factor in the resolution of the acne.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Acne Vulgaris / drug therapy*
  • Acne Vulgaris / microbiology
  • Adult
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Fatty Acids, Nonesterified / biosynthesis
  • Female
  • Humans
  • Isotretinoin
  • Male
  • Sebum / drug effects*
  • Skin / microbiology
  • Tretinoin / therapeutic use*

Substances

  • Fatty Acids, Nonesterified
  • Tretinoin
  • Isotretinoin